{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:41:58Z","timestamp":1787668918968,"version":"build-2736575974"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Prescription opioid use is common among men and women of reproductive age, including during assisted-reproduction procedures. Opioid use disorder and chronic use are associated with harms to fertility and pregnancy outcomes, but it is unclear whether these associations extend to common short-term patterns of prescription opioid use. We conducted a literature review using PubMed, Embase, Web of Science, and Scopus to identify studies of nonchronic, nondependent opioid use and reproductive endpoints including fertility, pregnancy loss, and pregnancy complications (i.e., preterm birth, birth weight, gestational diabetes, and hypertensive disorders of pregnancy). Seventeen studies were included. Although results of the studies suggest possible harms of short-term opioid use on fertility and pregnancy loss, methodologic limitations and the small number of studies make the literature inconclusive. This review highlights important data gaps that must be addressed to make conclusions about potential reproductive effects of short-term opioid use. These include the need for additional data on opioid use before clinically recognized pregnancy; accurate measurement of opioid exposure by multiple means with detailed information on the types and quantity of opioids used; assessment of important confounders, including opioid use indication, comorbidities, and use of other medications and substances; and studies of paternal opioid use, fertility, and pregnancy outcomes. A primary limitation of this review targeting studies of nonchronic opioid exposure is the possibility that selected studies included populations with unspecified chronic or dependent opioid use. Efforts to understand the impact of the prescription opioid epidemic should address potential reproductive harms of these medications among people of reproductive age.<\/jats:p>","DOI":"10.1093\/epirev\/mxaa007","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T21:37:40Z","timestamp":1601415460000},"page":"117-133","source":"Crossref","is-referenced-by-count":12,"title":["Prescription Opioid Use Among Populations of Reproductive Age: Effects on Fertility, Pregnancy Loss, and Pregnancy Complications"],"prefix":"10.1093","volume":"42","author":[{"given":"Kerry S","family":"Flannagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A","family":"Sjaarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunni L","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique F","family":"Schisterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2021021505084023300_ref1","year":"2019"},{"issue":"2","key":"2021021505084023300_ref2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature","volume":"4","author":"Yazdy","year":"2015","journal-title":"J Pediatr Genet."},{"issue":"2","key":"2021021505084023300_ref3","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics."},{"key":"2021021505084023300_ref4","doi-asserted-by":"crossref","first-page":"906723","DOI":"10.1155\/2014\/906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States","volume":"2014","author":"Whiteman","year":"2014","journal-title":"J Pregnancy."},{"issue":"6","key":"2021021505084023300_ref5","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021021505084023300_ref6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11934-016-0634-y","article-title":"Opioid-induced androgen deficiency (OPIAD): diagnosis, management, and literature review","volume":"17","author":"O'Rourke","year":"2016","journal-title":"Curr Urol Rep."},{"issue":"5","key":"2021021505084023300_ref7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med."},{"issue":"10","key":"2021021505084023300_ref8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use \u2013 United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2021021505084023300_ref9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMsa1807069","article-title":"Initial opioid prescriptions among U.S. commercially insured patients, 2012-2017","volume":"380","author":"Zhu","year":"2019","journal-title":"N Engl J Med."},{"issue":"8","key":"2021021505084023300_ref10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/j.pain.0000000000001242","article-title":"Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study","volume":"159","author":"Pasricha","year":"2018","journal-title":"Pain."},{"issue":"5","key":"2021021505084023300_ref11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among Medicaid-enrolled women","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol."},{"issue":"3","key":"2021021505084023300_ref12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/AOG.0000000000001868","article-title":"Filled prescriptions for opioids after vaginal delivery","volume":"129","author":"Jarlenski","year":"2017","journal-title":"Obstet Gynecol."},{"issue":"2","key":"2021021505084023300_ref13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/AOG.0000000000002741","article-title":"Frequency of opioid dispensing after vaginal delivery","volume":"132","author":"Prabhu","year":"2018","journal-title":"Obstet Gynecol."},{"issue":"1","key":"2021021505084023300_ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000002093","article-title":"Patterns of opioid prescription and use after cesarean delivery","volume":"130","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol."},{"issue":"4","key":"2021021505084023300_ref15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jmig.2017.11.005","article-title":"Opioid prescription and patient use after gynecologic procedures: a survey of patients and providers","volume":"25","author":"Griffith","year":"2018","journal-title":"J Minim Invasive Gynecol."},{"issue":"5","key":"2021021505084023300_ref16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.fertnstert.2018.06.023","article-title":"Opioid dispensing patterns after oocyte retrieval","volume":"110","author":"Bortoletto","year":"2018","journal-title":"Fertil Steril."},{"issue":"9","key":"2021021505084023300_ref17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med."},{"issue":"1","key":"2021021505084023300_ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems","volume":"31","author":"Vuong","year":"2010","journal-title":"Endocr Rev."},{"issue":"2","key":"2021021505084023300_ref19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2017.06.009","article-title":"Impact of the opioid system on the reproductive axis","volume":"108","author":"B\u00f6ttcher","year":"2017","journal-title":"Fertil Steril."},{"issue":"7\u20138","key":"2021021505084023300_ref20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2119\/molmed.2010.00268","article-title":"Regulation of male fertility by the opioid system","volume":"17","author":"Subir\u00e1n","year":"2011","journal-title":"Mol Med."},{"issue":"5","key":"2021021505084023300_ref21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1095\/biolreprod.115.128686","article-title":"Systemic morphine treatment derails normal uterine receptivity, leading to embryo implantation failure in mice","volume":"92","author":"Tang","year":"2015","journal-title":"Biol Reprod."},{"issue":"2","key":"2021021505084023300_ref22","first-page":"84","article-title":"Placental structure, function and drug transfer","volume":"15","author":"Griffiths","year":"2015","journal-title":"BJA Educ."},{"issue":"9","key":"2021021505084023300_ref23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejp.1256","article-title":"Increased risk of reproductive dysfunction in women prescribed long-term opioids for musculoskeletal pain: a matched cohort study in the clinical practice research Datalink","volume":"22","author":"Richardson","year":"2018","journal-title":"Eur J Pain."},{"issue":"1","key":"2021021505084023300_ref24","first-page":"103","article-title":"Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study","volume":"32","author":"McInerney","year":"2017","journal-title":"Hum Reprod."},{"issue":"23","key":"2021021505084023300_ref25","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/0024-3205(86)90209-2","article-title":"Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine","volume":"38","author":"Petraglia","year":"1986","journal-title":"Life Sci."},{"issue":"4","key":"2021021505084023300_ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000124091","article-title":"Morphine-induced TSH release in normal and hypothyroid subjects","volume":"40","author":"Devilla","year":"1985","journal-title":"Neuroendocrinology."},{"issue":"12","key":"2021021505084023300_ref27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1507\/endocrj.EJ11-0095","article-title":"Endocrine and behavioural effects of transdermal buprenorphine in pain-suffering women of different reproductive ages","volume":"58","author":"Aurilio","year":"2011","journal-title":"Endocr J."},{"issue":"3","key":"2021021505084023300_ref28","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1016\/j.fertnstert.2019.07.175","article-title":"Non-chronic preconception opioid use and reproductive outcomes","volume":"112","author":"Flannagan","year":"2019","journal-title":"Fertil Steril."},{"issue":"3","key":"2021021505084023300_ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211319","article-title":"Prescription medication use during pregnancies that resulted in births and abortions (2001-2013): a retrospective population-based study in a Canadian population","volume":"14","author":"Leong","year":"2019","journal-title":"PLoS One."},{"issue":"5","key":"2021021505084023300_ref30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5055\/jom.2019.0529","article-title":"Birth outcomes with prescribed chronic and acute opioid exposure during pregnancy","volume":"15","author":"Delate","year":"2019","journal-title":"J Opioid Manag."},{"issue":"12","key":"2021021505084023300_ref31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol."},{"issue":"3","key":"2021021505084023300_ref32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10995-014-1536-6","article-title":"Clinical correlates of prescription opioid analgesic use in pregnancy","volume":"19","author":"Smith","year":"2015","journal-title":"Matern Child Health J."},{"key":"2021021505084023300_ref33","first-page":"436","article-title":"Maternal opioid use and infant birth defects in RI Medicaid enrolled population","volume":"28","author":"Murray","year":"2019","journal-title":"Pharmacoepidem Dr S."},{"issue":"12","key":"2021021505084023300_ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study","volume":"16","author":"Sujan","year":"2019","journal-title":"PLoS Med."},{"issue":"12","key":"2021021505084023300_ref35","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/bcp.14117","article-title":"Maternal use of drugs and preeclampsia","volume":"85","author":"Sahlman","year":"2019","journal-title":"Br J Clin Pharmacol."},{"issue":"10","key":"2021021505084023300_ref36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals (Basel)."},{"issue":"7","key":"2021021505084023300_ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219061","article-title":"Pregnancy outcome following opioid exposure: a cohort study","volume":"14","author":"Fishman","year":"2019","journal-title":"PLoS One."},{"issue":"5","key":"2021021505084023300_ref38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics."},{"key":"2021021505084023300_ref39","first-page":"S75","article-title":"Use of legally prescribed opioid analgesics in pregnant women and risk of spontaneous preterm birth. A population based cohort study, Norway 2004-2008","volume":"20","author":"Handal","year":"2011","journal-title":"Pharmacoepidem Dr S."},{"issue":"1","key":"2021021505084023300_ref40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain."},{"key":"2021021505084023300_ref41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2014.10.013","article-title":"Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase","volume":"52","author":"Roche","year":"2015","journal-title":"Psychoneuroendocrinology."},{"issue":"6","key":"2021021505084023300_ref42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000003267","article-title":"Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines","volume":"133","author":"Lamvu","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"4","key":"2021021505084023300_ref43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med."},{"issue":"1","key":"2021021505084023300_ref44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: practical guide for clinicians","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clin Proc."},{"issue":"7411","key":"2021021505084023300_ref45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ."},{"key":"2021021505084023300_ref46","volume-title":"Obstetrics: Normal and Problem Pregnancies","author":"Gabbe","year":"2007","edition":"5th"},{"issue":"4","key":"2021021505084023300_ref47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2125.2012.04426.x","article-title":"Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases","volume":"75","author":"Engeland","year":"2013","journal-title":"Br J Clin Pharmacol."}],"container-title":["Epidemiologic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/epirev\/advance-article-pdf\/doi\/10.1093\/epirev\/mxaa007\/34037629\/mxaa007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/epirev\/article-pdf\/42\/1\/117\/36254629\/mxaa007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/epirev\/article-pdf\/42\/1\/117\/36254629\/mxaa007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T05:24:13Z","timestamp":1613366653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/epirev\/article\/42\/1\/117\/5916503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,1,31]]}},"URL":"https:\/\/doi.org\/10.1093\/epirev\/mxaa007","relation":{},"ISSN":["1478-6729"],"issn-type":[{"value":"1478-6729","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020]]},"published":{"date-parts":[[2020]]}}}